Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Liver Diseases

Free Subscription 31.08.2026 1 Biochem Biophys Res Commun 1 BMC Cancer 1 BMC Gastroenterol 8 Dig Dis Sci 2 Endoscopy 2 Gut 1 Hepatology 3 Indian J Gastroenterol 4 J Gastroenterol 1 J Gastroenterol Hepatol 3 J Hepatol 2 PLoS One 1 Proc Natl Acad Sci U S A 1 Radiol Imaging Cancer 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Biochem Biophys Res Commun

1. WANG S, Li C, Liu Y, Xu L, et al
   Effects of moderate- and high-intensity aerobic exercise on hepatic iron homeostasis, ferroptosis-related changes, and lipid metabolism in high-fat diet-induced MASLD rats.
   Biochem Biophys Res Commun. 2026;834:154467.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. YUE X, Kong Y, Huang X, Tang F, et al
   Impact of time to ablation on survival outcomes in patients with colorectal liver metastases: an inverse probability-weighted cohort study.
   BMC Cancer. 2026;26:1011.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

3. MOHAMMADZADEH N, Daeechini AH, Paghe A, Laktarashi HV, et al
   Evaluation of fatty liver disease self-care applications: a systematic review and evaluation of apps using the mobile application rating scale (MARS).
   BMC Gastroenterol. 2026;26:521.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

4. HARIHARAN P, Aboona MB, Foote J, Ghani L, et al
   Racial Disparities in Clinical and Cardiometabolic Outcomes Among Patients with Alcohol-Associated Liver Disease.
   Dig Dis Sci. 2026;71:4340-4349.
   PubMed         Abstract available
   
   
5. MCNALLY BB, Carey EJ
   The Nutrition Landscape in Chronic Liver Disease.
   Dig Dis Sci. 2026;71:4455-4461.
   PubMed         Abstract available
   
   
6. PARK SE, Wollstein Y, Hutchison AL, Paul S, et al
   Recruitment of Minority Patients in Metabolic Dysfunction-Associated Steatotic Liver Disease Clinical Trials.
   Dig Dis Sci. 2026;71:4235-4241.
   PubMed         Abstract available
   
   
7. SHETTY A, Rahal K, Meza J, Saab S, et al
   Gastroenterologist's Guide to Assess for Alcohol Use.
   Dig Dis Sci. 2026;71:4443-4454.
   PubMed         Abstract available
   
   
8. LIOU WL, Pei Y, Teh KK, Cheah MC, et al
   Safety of Statins in an Asian Cohort with Biopsy Proven Metabolic Dysfunction-Associated Steatotic Liver Disease.
   Dig Dis Sci. 2026;71:3709-3716.
   PubMed         Abstract available
   
   
9. LIU KS, Liu KE, Sokale IO, Chen Y, et al
   Food Insecurity and Poverty Are Associated with Increased Risk for MASLD Among US Adults.
   Dig Dis Sci. 2026;71:3602-3613.
   PubMed         Abstract available
   
   
10. HUANG D, Zhu Z
    CircRSF1 Promoted HepG2 Cell Proliferation, Migration and Invasion Depending on EIF4A3.
    Dig Dis Sci. 2026;71:3539-3548.
    PubMed         Abstract available
    
    
11. NJEI B, Tanih DN, Al-Ajlouni YA, Boateng S, et al
    AI-Based Screening for At-Risk MASLD and Advanced Fibrosis in the US Population: A Cost-Effectiveness Analysis.
    Dig Dis Sci. 2026;71:3476-3488.
    PubMed         Abstract available
    
    

    
    Endoscopy

12. TAKAHASHI T, Tomishima K, Takasaki Y, Iwabe Y, et al
    Cholangioscopy-guided holmium laser ablation for stent-related mucosal hyperplasia causing recurrent cholangitis after endoscopic ultrasound-guided hepaticogastrostomy.
    Endoscopy. 2026 Aug 27. doi: 10.1055/a-2921-6146.
    PubMed        
    
    
13. ASAHINA F, Sagami R, Agario T, Hiroshima Y, et al
    Bile duct stone removal via an endoscopic ultrasound guided-hepaticogastrostomy route created using a B1 puncture technique.
    Endoscopy. 2026 Aug 27. doi: 10.1055/a-2919-0092.
    PubMed        
    
    

    
    Gut

14. JEFFREY AW, Tsochatzis EA, Genesca J, Adams LA, et al
    From pressure to prognosis: establishing a common language for portal hypertension in advanced chronic liver disease.
    Gut. 2026 Aug 25:gutjnl-2026-339845. doi: 10.1136/gutjnl-2026-339845.
    PubMed         Abstract available
    
    
15. ZHU J, Zhang C
    Mortality prediction by rate of skeletal muscle loss in cirrhosis: some methodological considerations.
    Gut. 2026 Aug 24:gutjnl-2026-340267. doi: 10.1136/gutjnl-2026-340267.
    PubMed        
    
    

    
    Hepatology

16. BASTAICH D, Dahman B, Hentschel A, Karki C, et al
    Beyond cirrhosis: Major adverse liver outcomes across homozygous and heterozygous Alpha-1 antitrypsin deficiency associated liver disease.
    Hepatology. 2026 Aug 28. doi: 10.1097/HEP.0000000000001854.
    PubMed         Abstract available
    
    

    
    Indian J Gastroenterol

17. ANIRVAN P
    ALBI, EZ-ALBI and sarcopenia in hepatocellular carcinoma: Prognostic refinement or repackaging of established risk?
    Indian J Gastroenterol. 2026 Aug 26. doi: 10.1007/s12664-026-02068.
    PubMed        
    
    
18. JIANG W
    Reconsidering splenic stiffness measurement for non-invasive esophageal variceal screening in cirrhosis.
    Indian J Gastroenterol. 2026 Aug 24. doi: 10.1007/s12664-026-02055.
    PubMed        
    
    
19. VERMA A, Giri S, Sahu SK, Priyadarshini S, et al
    Author's Reply: Reconsidering splenic stiffness measurement for non-invasive esophageal variceal screening in cirrhosis.
    Indian J Gastroenterol. 2026 Aug 28. doi: 10.1007/s12664-026-02062.
    PubMed        
    
    

    
    J Gastroenterol

20. OBA A, Taguchi T, Fujikawa N, Okami S, et al
    Clinical significance of gadoxetate sodium-enhanced MRI for detecting liver metastasis in patients with pancreatic cancer: decadal real-world data analysis in Japan.
    J Gastroenterol. 2026 May 4. doi: 10.1007/s00535-026-02431.
    PubMed         Abstract available
    
    
21. NAKAJIMA A, Okanoue T, Hiasa Y, Takahashi H, et al
    Semaglutide in Japanese participants with metabolic dysfunction-associated steatohepatitis: a subgroup analysis of the ESSENCE trial.
    J Gastroenterol. 2026 Aug 28. doi: 10.1007/s00535-026-02507.
    PubMed         Abstract available
    
    
22. HASHIMOTO D, Ikeura T, Maekawa A, Nakajima T, et al
    Conversion surgery for unresectable pancreatic ductal adenocarcinoma with liver metastasis at initial diagnosis: a nationwide multicenter study.
    J Gastroenterol. 2026 May 4. doi: 10.1007/s00535-026-02432.
    PubMed         Abstract available
    
    
23. SOUSA JM, Rodriguez-Tajes S, Hernandez-Guerra M, Casado M, et al
    Prevalence and incidence of chronic kidney disease in patients with primary biliary cholangitis.
    J Gastroenterol. 2026 Jun 22. doi: 10.1007/s00535-026-02442.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

24. YI H, Lee HW, Shin JI, Lee HW, et al
    Comparable Predictive Performance of Non-VCTE-Based Machine Learning Model for HBV-Infected Hepatocellular Carcinoma Risk.
    J Gastroenterol Hepatol. 2026 Aug 27. doi: 10.1111/jgh.70686.
    PubMed         Abstract available
    
    

    
    J Hepatol

25. CHEW V
    Hepatic steatosis as an architect of CRC metastatic niche.
    J Hepatol. 2026 Aug 25:S0168-8278(26)02842-4. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    
26. HEDELUND RONN J, Jepsen P, Mellinger J, Innes H, et al
    Alcohol, Cardiometabolic Risk Factors, and Cirrhosis: Ten-Year Risk Estimates from a Population-based Danish Cohort.
    J Hepatol. 2026 Aug 24:S0168-8278(26)02860-6. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    
27. SELICEAN SE, Vaisanen E, Wehmeyer M, Hubener P, et al
    Histology alone may underestimate liver cirrhosis despite adequate biopsy quality: evidence from minilaparoscopic liver biopsies.
    J Hepatol. 2026 Aug 27:S0168-8278(26)02857-6. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    

    
    PLoS One

28. CEBALLOS L, Canton C, Gayo V, Moreno L, et al
    Pharmacokinetic barriers to oxfendazole flukicidal efficacy.
    PLoS One. 2026;21:e0355551.
    PubMed         Abstract available
    
    
29. WU R, Xing H, Townsend JP
    Driver mutation impact in Chinese hepatocellular carcinoma.
    PLoS One. 2026;21:e0355717.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

30. NEMATI H, Suijkerbuijk SJE, de Graaf J
    Cell competition driven by secreted ligands: Modeling liver metastasis of colorectal cancer.
    Proc Natl Acad Sci U S A. 2026;123:e2531078123.
    PubMed         Abstract available
    
    

    
    Radiol Imaging Cancer

31. KJAERGAARD U, Bogh N, Aastrup M, Kristensen MH, et al
    Proof-of-Concept Study of Hyperpolarized [1-(13)C]Pyruvate MRI in Participants with Hepatocellular Carcinoma.
    Radiol Imaging Cancer. 2026;8:e250784.
    PubMed         Abstract available
    
    

    
    Transplantation

32. ROBITSCHEK E, Bastani A, Lev S, Horwath K, et al
    Higher Medical Urgency Is Associated With Greater Psychosocial Risk Tolerance in Liver Transplant Listing and Selection.
    Transplantation. 2026 Jun 17. doi: 10.1097/TP.0000000000005800.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum